Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Category: Conferences
-
The USPTO contacted me yesterday and requested that I post the following announcement: The U.S. Patent and Trademark Office (USPTO) will hold a special webinar on Thursday, August 23, 2007, at 1:00 p.m. (EST) on new claims and continuations rules that will allow the agency to continue to make the patent examination process more effective…
-
Informa Life Sciences “European Pharmaceutical Law Forum” Conference, Washington D.C., October 23-25
Informa Life Sciences will be presenting a unique conference entitled "European Pharmaceutical Law Forum" in Washington, D.C., October 23-25. The conference will provide an invaluable introduction to the laws and regulations governing the pharmaceutical, biotech and generics industries in Europe. At this premier global event you will be brought up-to-date with the key European cases…
-
American Conference Institute’s popular "FDA Boot Camp" returns to the University of Chicago’s Gleacher Center in downtown Chicago on September 25-26. ACI expects a sell-out of this conference and recommends early registration. The conference is designed to give patent lawyers, product liability lawyers, and life sciences investment and securities experts a strong working knowledge of…
-
Scherago International has announced "Biosimilars 2007," a two day conference to "air the issues" and "raise the questions" associated with biosimilars (also called follow-on biologics or biogenerics). The conference will be held September 24-25 in the Jack Morton Auditorium on the campus of George Washington University, in Washington D.C. Speakers include leaders in Congress working…
-
American Conference Institute’s popular "FDA Boot Camp" comes to Boston on July 17-18. According to ACI, seats at this year’s New York and last year’s Chicago editions sold out. The conference is designed to give patent lawyers, product liability lawyers, and life sciences investment and securities experts "a strong working knowledge of core FDA regulatory…
-
Informa Life Sciences will hold its 2nd annual "Legal Strategies for Developing Generic Medicines" conference July 9-11 in Amsterdam, The Netherlands. ILS announces that the conference offers "the unrivalled opportunity to hear how the latest updates in the European Pharmaceutical Legislation and issues in patent litigation will affect your generics business." According to the conference…
-
American Conference Institute plans to hold a two-day “Pharma/Biotech Patent Boot Camp” on June 21-22 in New York. According to ACI, the conference “has been designed to give new patent attorneys and patent attorneys who are new to the life sciences industries–as well as business executives in pharma and biotech companies–a strong working knowledge of essential IP…
-
American Conference Institute will hold the 2nd west coast edition of its popular "Maximizing Pharmaceutical Patent Life Cycles" conference next week in San Francisco (at the beautiful Mark Hopkins hotel). ACI calls this "the only Hatch-Waxman conference specifically designed for the biopharmaceutical industry." According to ACI, the conference will "bring the biopharmaceutical industry the critical…
-
American Conference Institute is planning another “FDA Boot Camp” conference for May 15-16 in San Francisco. Prior versions of this conference in New York and Chicago were very popular. According to ACI, “FDA Boot Camp has been designed to give product or patent litigators, as well as patent prosecutors and life sciences investment and securities experts, a strong working…
-
Law Seminars International will be holding a conference on Pharmaceutical Antitrust next week in Washington. David Balto, one of the co-chairs of the conference, recently made the following announcement: There will be a keynote address by FTC Commissioner Tom Rosch, who has interesting views on the ever contentious patent settlement issues. Rosch is expected to say something new and noteworthy that will provide…
